In this Newsletter:
User Group Meeting
Tuesday, October 29, 2013
8:30am - 4:00pm
Royal Sonesta Hotel
The Hepregen User Group Meeting will bring together users and prospective users of Hepregen's HepatoPac® micro-liver platform to discuss practical applications and new products in the fields of drug metabolism and toxicology. Please join us for lectures in DMPK, Toxicology and New Applications as well as a variety of round table discussions. More Information
Keynote: Use of HepatoPac™ - An Improved In Vitro Model for Metabolite Identification and Compound Stability.
Edward LeCluyse, The Hamner Institute for Health Sciences
Evaluation of the Toxicity Profiles of Selected Biogen Idec Compounds in Rat HepatoPac™ Co-Culture.
David Peters, Ph.D., Biogen
Comparative Metabolism of Eight Model Pharmaceutical Compounds in Rat and Human - Liver Microsomes, Suspension Hepatocytes and the Hepregen HepatoPac™ Micropatterned Co-culture Platform.
Julius O. Enoru, Ph.D. and William DeMaio, Ph.D. , Ricerca
Minimizing Late Stage Human Specific Metabolite Surprises with HepatoPac™ Cultures: The Loratadine Story.
Ragu Ramanathan, Ph.D., QPS
Application of Whole Hepatocyte Systems for Predicting In Vivo Relevant Drug Interactions.
Kenneth Brouwer, Ph.D., RPh., Qualyst Transporter Solutions
In Vitro Characterization of Phase I and Phase II Drug Metabolism in Human, Rat, and Monkey HepatoPac™.
Yvonne Schaus, Ph.D., Hepregen
Expanded Product Line
Now Available in 4 Formats
- Human Triple Donor
- Rat/Human Multi-species
Meeting up with Hegregen
AAPS Annual Meeting
November 10-14, 2013
San Antonio, TX
Poster: A Micropatterned Culture with Primary Hepatocytes and Kupffer Macrophages for Studying Inflammation - Drug Interaction.
Poster - Bioactivation and Toxicity of Acetaminophen in Rat Primary Hepatocytes Cultured in Micropatterned Co-cultures.